GLP1R and Alzheimer disease: Given that GLP-1 receptor agonists are injectable formulations, patients require a better understanding of how to use them compared to other antidiabetic drugs.44 That is, patients taking GLP-1 receptor agonists may already have higher cognitive function, which might be one of the reasons for the lower risk of AD when patients use GLP-1 receptor agonists.